Adebrelimab (SHR-1316) is a humanized IgG4 monoclonal PD-L1 (PD-1/PD-L1) antibody. Adebrelimab has promising antitumor activity in solid tumors including extensive-stage small-cell lung cancer (SCLC).
Purity:
>95.0%
CAS Number:
[2247114-85-6]
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted
